WHEN: June 2nd 11:30-13:30
WHERE: ZOOM – the ZOOM link will be sent out to the email you provide in the registration link below.
Karolinska Institutet is world recognized as the experts in NK cells. KI researchers not only discovered the cell type in the mid-70s but also discovered their ability to identify tumour cells in the 80s. KI Flemingsberg continues to lead the way in this field in both research and product development of NK cell based patient solutions.
We welcome you to login to our ZOOM session and eat your lunch with us to hear about these great NK activities that are well under way in Sweden. The presentations will be 20 minutes followed by 10 minutes for questions and discussion as well as a bio-break before the next speaker.
11:30 – Introduction, welcome Lilian Walther Jallow
11:35 – Evren Alici – NextGenNK centre of excellence, Karolinska Institutet
“NextGenNK National Competence center: Our mission and current activities”
12:05 – Johan Liwing – CEO CellProtect
“Sweden’s leading position in NK cell therapies and the CellProtect goals for the next 5 years”
12:35 – Nicole Marquardt – Karolinska Institutet
“Human tissue-resident NK cells and their role in tissue-specific pathologies”
13:00 – Reflections and information on next ATMP Flemingsberg event